STOCK TITAN

[424B5] Neuphoria Therapeutics Inc. Prospectus Supplement (Debt Securities)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B5
Rhea-AI Filing Summary

On 29 July 2025, Solaris Resources Inc. (SLSR) submitted a Form 6-K reporting a change of auditor. Three exhibits accompany the filing: (i) “Notice of Change of Auditor,” (ii) KPMG’s response letter, and (iii) BDO’s response letter. While the body of the 6-K provides no financial data, the exhibit titles imply KPMG LLP is the outgoing auditor and BDO is the incoming firm. The report contains no disclosure of disagreements, restatements, or timing details—those elements, if any, are expected within the exhibits. The document is signed by CFO & Secretary Richard Hughes, indicating board authorization.

Auditor changes can affect perceived governance quality, audit continuity, and filing timelines; investors should review the attached notices for any “reportable events” under PCAOB or Canadian securities rules. Absent further information, the filing is procedural but warrants monitoring until the full rationale and impacts on future financial reporting are clarified.

Il 29 luglio 2025, Solaris Resources Inc. (SLSR) ha presentato un modulo 6-K comunicando un cambio di revisore. La documentazione allegata include tre exhibit: (i) “Avviso di Cambio del Revisore,” (ii) la lettera di risposta di KPMG, e (iii) la lettera di risposta di BDO. Sebbene il corpo del 6-K non contenga dati finanziari, i titoli degli exhibit suggeriscono che KPMG LLP è il revisore uscente mentre BDO è il nuovo incaricato. Il rapporto non riporta disaccordi, rettifiche o dettagli temporali; tali informazioni, se presenti, dovrebbero trovarsi negli exhibit. Il documento è firmato dal CFO e Segretario Richard Hughes, a conferma dell’autorizzazione del consiglio.

Il cambio del revisore può influenzare la percezione della qualità della governance, la continuità della revisione e le tempistiche di deposito; gli investitori dovrebbero esaminare gli avvisi allegati per eventuali “eventi segnalabili” secondo le normative PCAOB o canadesi. In assenza di ulteriori dettagli, la comunicazione è di natura procedurale ma richiede monitoraggio fino a chiarimenti completi sulle motivazioni e sugli effetti futuri sulla rendicontazione finanziaria.

El 29 de julio de 2025, Solaris Resources Inc. (SLSR) presentó un Formulario 6-K informando un cambio de auditor. La presentación incluye tres anexos: (i) “Aviso de Cambio de Auditor,” (ii) carta de respuesta de KPMG, y (iii) carta de respuesta de BDO. Aunque el cuerpo del 6-K no contiene datos financieros, los títulos de los anexos sugieren que KPMG LLP es el auditor saliente y BDO el entrante. El informe no menciona desacuerdos, rectificaciones ni detalles de tiempos; estos elementos, si existen, se esperan en los anexos. El documento está firmado por el CFO y Secretario Richard Hughes, indicando la autorización del consejo.

Los cambios de auditor pueden afectar la percepción de la calidad de gobierno corporativo, la continuidad de la auditoría y los plazos de presentación; los inversores deben revisar los avisos adjuntos para identificar cualquier “evento reportable” según las normas PCAOB o de valores canadienses. Sin información adicional, la presentación es de carácter procedimental pero debe ser monitoreada hasta que se clarifiquen las razones y los impactos en reportes financieros futuros.

2025년 7월 29일, Solaris Resources Inc.(SLSR)는 감사인 변경을 보고하는 Form 6-K를 제출했습니다. 제출서류에는 세 가지 부속서가 포함되어 있습니다: (i) “감사인 변경 통지,” (ii) KPMG의 답변서, 그리고 (iii) BDO의 답변서. 6-K 본문에는 재무 데이터가 없으나, 부속서 제목으로 볼 때 KPMG LLP가 퇴임 감사인이고 BDO가 신규 감사인임을 알 수 있습니다. 보고서에는 이견, 정정 또는 일정 관련 세부사항이 없으며, 이러한 내용은 부속서에 포함될 것으로 예상됩니다. 문서는 CFO 겸 비서인 Richard Hughes가 서명하여 이사회 승인을 나타냅니다.

감사인 변경은 거버넌스 품질 인식, 감사 연속성 및 제출 일정에 영향을 줄 수 있으므로, 투자자들은 PCAOB 또는 캐나다 증권 규정에 따른 “보고 대상 사건” 여부를 확인하기 위해 첨부된 통지문을 검토해야 합니다. 추가 정보가 없는 한 이번 제출은 절차적 성격이지만, 전체 사유와 향후 재무 보고에 미칠 영향이 명확해질 때까지 주의 깊게 모니터링할 필요가 있습니다.

Le 29 juillet 2025, Solaris Resources Inc. (SLSR) a soumis un formulaire 6-K annonçant un changement d’auditeur. Trois annexes accompagnent ce dépôt : (i) « Avis de changement d’auditeur », (ii) la lettre de réponse de KPMG, et (iii) la lettre de réponse de BDO. Bien que le corps du 6-K ne contienne aucune donnée financière, les titres des annexes suggèrent que KPMG LLP est l’auditeur sortant et BDO le nouvel auditeur. Le rapport ne mentionne aucun désaccord, rectification ou détail temporel – ces éléments, s’ils existent, devraient se trouver dans les annexes. Le document est signé par le CFO et secrétaire Richard Hughes, ce qui indique une autorisation du conseil d’administration.

Un changement d’auditeur peut influencer la perception de la qualité de la gouvernance, la continuité de l’audit et les délais de dépôt ; les investisseurs doivent examiner les avis joints pour détecter tout « événement déclarable » selon les règles PCAOB ou canadiennes. En l’absence d’informations supplémentaires, ce dépôt est de nature procédurale mais mérite d’être suivi jusqu’à ce que les raisons complètes et les impacts sur les rapports financiers futurs soient clarifiés.

Am 29. Juli 2025 reichte Solaris Resources Inc. (SLSR) ein Formular 6-K ein, in dem ein Wechsel des Abschlussprüfers gemeldet wird. Der Einreichung sind drei Anhänge beigefügt: (i) „Mitteilung über den Wechsel des Abschlussprüfers“, (ii) Antwortschreiben von KPMG und (iii) Antwortschreiben von BDO. Obwohl der Hauptteil des 6-K keine Finanzdaten enthält, deuten die Titel der Anhänge darauf hin, dass KPMG LLP der scheidende Prüfer und BDO die neue Prüfergesellschaft ist. Der Bericht enthält keine Angaben zu Meinungsverschiedenheiten, Berichtigungen oder Zeitangaben – diese Informationen sind gegebenenfalls in den Anhängen zu finden. Das Dokument ist vom CFO und Sekretär Richard Hughes unterzeichnet, was auf die Zustimmung des Vorstands hinweist.

Wechsel des Abschlussprüfers können die Wahrnehmung der Governance-Qualität, die Kontinuität der Prüfung und die Einreichungsfristen beeinflussen; Investoren sollten die beigefügten Mitteilungen auf „meldepflichtige Ereignisse“ gemäß PCAOB- oder kanadischen Wertpapierregelungen prüfen. Ohne weitere Informationen ist die Einreichung formell, sollte aber beobachtet werden, bis die vollständigen Gründe und Auswirkungen auf künftige Finanzberichte geklärt sind.

Positive
  • None.
Negative
  • Auditor transition introduces uncertainty until reasons, disagreements, or timing are clarified, potentially affecting investor confidence and future reporting timelines.

Insights

TL;DR – Auditor switch disclosed; impact unclear pending exhibit details.

The 6-K merely announces Solaris’ transition from KPMG to BDO. Without the exhibits, we cannot judge whether the change stems from routine rotation, cost savings, or disputes. Such moves are typically neutral but can raise flags if disagreements or scope limitations are cited. Investors should scrutinize the letters for PCAOB “reportable events” (e.g., GAAP disagreements, internal-control issues). Until clarified, I view the development as low immediate impact yet worth tracking ahead of the next audited financials.

Il 29 luglio 2025, Solaris Resources Inc. (SLSR) ha presentato un modulo 6-K comunicando un cambio di revisore. La documentazione allegata include tre exhibit: (i) “Avviso di Cambio del Revisore,” (ii) la lettera di risposta di KPMG, e (iii) la lettera di risposta di BDO. Sebbene il corpo del 6-K non contenga dati finanziari, i titoli degli exhibit suggeriscono che KPMG LLP è il revisore uscente mentre BDO è il nuovo incaricato. Il rapporto non riporta disaccordi, rettifiche o dettagli temporali; tali informazioni, se presenti, dovrebbero trovarsi negli exhibit. Il documento è firmato dal CFO e Segretario Richard Hughes, a conferma dell’autorizzazione del consiglio.

Il cambio del revisore può influenzare la percezione della qualità della governance, la continuità della revisione e le tempistiche di deposito; gli investitori dovrebbero esaminare gli avvisi allegati per eventuali “eventi segnalabili” secondo le normative PCAOB o canadesi. In assenza di ulteriori dettagli, la comunicazione è di natura procedurale ma richiede monitoraggio fino a chiarimenti completi sulle motivazioni e sugli effetti futuri sulla rendicontazione finanziaria.

El 29 de julio de 2025, Solaris Resources Inc. (SLSR) presentó un Formulario 6-K informando un cambio de auditor. La presentación incluye tres anexos: (i) “Aviso de Cambio de Auditor,” (ii) carta de respuesta de KPMG, y (iii) carta de respuesta de BDO. Aunque el cuerpo del 6-K no contiene datos financieros, los títulos de los anexos sugieren que KPMG LLP es el auditor saliente y BDO el entrante. El informe no menciona desacuerdos, rectificaciones ni detalles de tiempos; estos elementos, si existen, se esperan en los anexos. El documento está firmado por el CFO y Secretario Richard Hughes, indicando la autorización del consejo.

Los cambios de auditor pueden afectar la percepción de la calidad de gobierno corporativo, la continuidad de la auditoría y los plazos de presentación; los inversores deben revisar los avisos adjuntos para identificar cualquier “evento reportable” según las normas PCAOB o de valores canadienses. Sin información adicional, la presentación es de carácter procedimental pero debe ser monitoreada hasta que se clarifiquen las razones y los impactos en reportes financieros futuros.

2025년 7월 29일, Solaris Resources Inc.(SLSR)는 감사인 변경을 보고하는 Form 6-K를 제출했습니다. 제출서류에는 세 가지 부속서가 포함되어 있습니다: (i) “감사인 변경 통지,” (ii) KPMG의 답변서, 그리고 (iii) BDO의 답변서. 6-K 본문에는 재무 데이터가 없으나, 부속서 제목으로 볼 때 KPMG LLP가 퇴임 감사인이고 BDO가 신규 감사인임을 알 수 있습니다. 보고서에는 이견, 정정 또는 일정 관련 세부사항이 없으며, 이러한 내용은 부속서에 포함될 것으로 예상됩니다. 문서는 CFO 겸 비서인 Richard Hughes가 서명하여 이사회 승인을 나타냅니다.

감사인 변경은 거버넌스 품질 인식, 감사 연속성 및 제출 일정에 영향을 줄 수 있으므로, 투자자들은 PCAOB 또는 캐나다 증권 규정에 따른 “보고 대상 사건” 여부를 확인하기 위해 첨부된 통지문을 검토해야 합니다. 추가 정보가 없는 한 이번 제출은 절차적 성격이지만, 전체 사유와 향후 재무 보고에 미칠 영향이 명확해질 때까지 주의 깊게 모니터링할 필요가 있습니다.

Le 29 juillet 2025, Solaris Resources Inc. (SLSR) a soumis un formulaire 6-K annonçant un changement d’auditeur. Trois annexes accompagnent ce dépôt : (i) « Avis de changement d’auditeur », (ii) la lettre de réponse de KPMG, et (iii) la lettre de réponse de BDO. Bien que le corps du 6-K ne contienne aucune donnée financière, les titres des annexes suggèrent que KPMG LLP est l’auditeur sortant et BDO le nouvel auditeur. Le rapport ne mentionne aucun désaccord, rectification ou détail temporel – ces éléments, s’ils existent, devraient se trouver dans les annexes. Le document est signé par le CFO et secrétaire Richard Hughes, ce qui indique une autorisation du conseil d’administration.

Un changement d’auditeur peut influencer la perception de la qualité de la gouvernance, la continuité de l’audit et les délais de dépôt ; les investisseurs doivent examiner les avis joints pour détecter tout « événement déclarable » selon les règles PCAOB ou canadiennes. En l’absence d’informations supplémentaires, ce dépôt est de nature procédurale mais mérite d’être suivi jusqu’à ce que les raisons complètes et les impacts sur les rapports financiers futurs soient clarifiés.

Am 29. Juli 2025 reichte Solaris Resources Inc. (SLSR) ein Formular 6-K ein, in dem ein Wechsel des Abschlussprüfers gemeldet wird. Der Einreichung sind drei Anhänge beigefügt: (i) „Mitteilung über den Wechsel des Abschlussprüfers“, (ii) Antwortschreiben von KPMG und (iii) Antwortschreiben von BDO. Obwohl der Hauptteil des 6-K keine Finanzdaten enthält, deuten die Titel der Anhänge darauf hin, dass KPMG LLP der scheidende Prüfer und BDO die neue Prüfergesellschaft ist. Der Bericht enthält keine Angaben zu Meinungsverschiedenheiten, Berichtigungen oder Zeitangaben – diese Informationen sind gegebenenfalls in den Anhängen zu finden. Das Dokument ist vom CFO und Sekretär Richard Hughes unterzeichnet, was auf die Zustimmung des Vorstands hinweist.

Wechsel des Abschlussprüfers können die Wahrnehmung der Governance-Qualität, die Kontinuität der Prüfung und die Einreichungsfristen beeinflussen; Investoren sollten die beigefügten Mitteilungen auf „meldepflichtige Ereignisse“ gemäß PCAOB- oder kanadischen Wertpapierregelungen prüfen. Ohne weitere Informationen ist die Einreichung formell, sollte aber beobachtet werden, bis die vollständigen Gründe und Auswirkungen auf künftige Finanzberichte geklärt sind.

Filed pursuant to Rule 424(b)(5)

Registration No. 333-283306

 

AMENDMENT NO. 3, dated July 29, 2025,

to PROSPECTUS SUPPLEMENT dated January 6, 2025

 

Up to $6,337,229

 

 

Common Stock

 

This Amendment No. 3 to Prospectus Supplement (this “Amendment”) amends and updates our prospectus supplement, dated January 6, 2025, filed with the Securities and Exchange Commission as part of our registration statement on Form S-3, File No. 333-283306 (the “Prospectus Supplement”). This Amendment should be read in conjunction with the Prospectus Supplement and the accompanying prospectus dated January 6, 2025 (the “Prospectus”), each of which are to be delivered with this Amendment, as well as any of our SEC filings which amend and update this Prospectus Supplement. This Amendment amends and/or updates only those sections of the Prospectus Supplement set forth in this Amendment; all other sections of the Prospectus Supplement remain unchanged. This Amendment is not complete without, and may only be delivered or utilized in connection with, the Prospectus Supplement, and any future amendments or supplements hereto or thereto.

 

We have entered into an At The Market Offering Agreement, or the Sales Agreement, with H.C. Wainwright & Co., LLC, or Wainwright, dated November 18, 2024. Under this Sales Agreement, as updated by this Amendment, we may offer and sell common stock having an aggregate offering price of up to $6,337,229 from time to time through Wainwright, acting as sales agent, in accordance with the Sales Agreement.

 

Sales of the common stock, if any, under this prospectus, as amended, may be made by any method permitted that is deemed an “at the market” offering as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act. Wainwright may sell our common stock by any method permitted by law deemed to be an at-the-market offering as defined in Rule 415(a)(4) promulgated under the Securities Act. Wainwright is not required to sell any specific number or dollar amount of securities but will act as our sales agent using commercially reasonable efforts consistent with their normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq, on mutually agreed terms between the Wainwright and us. There are no minimum sale requirements, and there is no arrangement for funds to be received in any escrow, trust or similar arrangement.

 

We are filing this Amendment to amend the Prospectus Supplement solely to update the amount of shares of common stock we are eligible to sell under General Instruction I.B.6 of Form S-3 and pursuant to the Sales Agreement. As of July 28, 2025, the aggregate market value of our common stock held by non-affiliates, or public float, was approximately $19,011,687 based on 2,261,624 shares of common stock outstanding (less any insider holdings), based on a closing price of $8.69 per share on July 28, 2025, which was the highest closing sale price of our common stock on the Nasdaq Global Market, the principal market for our common equity, within 60 days of the filing date of this registration statement, as amended. In the past 12 calendar months, we have offered and sold an aggregate of $4,394,848 securities pursuant to General Instruction I.B.6 of Form S-3. In no event will we sell securities registered on this registration statement in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75.0 million.

 

Wainwright will be entitled to a commission of 3.0% of the gross sales price per share sold under the Sales Agreement. See “Plan of Distribution” beginning on page S-11 of our prospectus supplement, dated January 6, 2025 for additional information regarding the compensation to be paid to Wainwright. In connection with the sale of the common stock on our behalf, Wainwright will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation paid to Wainwright will be deemed to be underwriting compensation. We have also agreed in the Sales Agreement to provide indemnification and contribution to Wainwright with respect to certain liabilities, including liabilities under the Securities Act.

 

Our common stock is listed on the Nasdaq under the symbol “NEUP.” On July 28, 2025, the last reported sale price of our common stock on the Nasdaq was $8.69 per share.

 

INVESTING IN OUR COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. BEFORE MAKING AN INVESTMENT DECISION, PLEASE READ THE INFORMATION UNDER THE HEADING “RISK FACTORS” BEGINNING ON PAGE S-6 OF THIS PROSPECTUS SUPPLEMENT, AND IN THE DOCUMENTS INCORPORATED BY REFERENCE INTO THIS PROSPECTUS SUPPLEMENT.

 

Neither the Securities and Exchange Commission, any state securities commission, nor any other foreign securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a criminal offense.

 

H.C. Wainwright & Co.

 

The date of this Amendment No. 3 to prospectus supplement is July 29, 2025.

 

FAQ

Why did Solaris Resources (SLSR) file this Form 6-K?

To notify regulators of a change of auditor and submit related correspondence from KPMG and BDO.

Which firms are involved in Solaris Resources' auditor change?

The filing lists KPMG LLP (outgoing) and BDO (incoming) in the response letters.

Does the 6-K include financial results or guidance?

No. The report contains no earnings data, balance sheets, or guidance; it is strictly about the auditor transition.

What should investors watch for following the auditor change?

Review the exhibits for reportable events or disagreements and monitor upcoming filings for impacts on audit timelines.
Neuphoria Therapeutics Inc

NASDAQ:NEUP

NEUP Rankings

NEUP Latest News

NEUP Latest SEC Filings

NEUP Stock Data

15.34M
1.63M
0.53%
67%
0.66%
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGTON